- The bivalent mRNA boosters from Pfizer-BioNTech and Moderna were 48% effective against symptomatic infection from the predominant omicron subvariant (XBB/XBB.1.5) in persons aged 18-49 years according to early data published by the CDC https://www.nbcnews.com/health/health-news/updated-covid-boosters-cut-infection-risk-xbb15-subvariant-half-cdc-fi-rcna67313 57 comments science
Linked pages
- CDC COVID Data Tracker https://covid.cdc.gov/covid-data-tracker/#trends_dailycases 531 comments
- FDA authorizes Pfizer's and Moderna's updated Covid booster shots https://www.nbcnews.com/health/health-news/fda-authorizes-pfizers-modernas-updated-covid-booster-shots-rcna44825 7 comments
- Omicron BA.5, BA.4 Covid symptoms: New subvariants better at evading immune protection https://www.nbcnews.com/health/health-news/omicron-ba5-ba4-covid-symptoms-vaccines-rcna36894#amp_tf=From%20%251%24s&aoh=16573260571608&csi=0&referrer=https%3A%2F%2Fwww.google.com&share=https%3A%2F%2Fwww.nbcnews.com%2Fhealth%2Fhealth-news%2Fomicron-ba5-ba4-covid-symptoms-vaccines-rcna36894 4 comments
- XBB.1.5 subvariant: CDC reports new omicron strain taking over https://www.nbcnews.com/health/health-news/xbb15-subvariant-cdc-reports-new-omicron-strain-taking-rcna63512 0 comments
Related searches:
Search whole site: site:www.nbcnews.com
Search title: Updated Covid boosters cut the infection risk from XBB.1.5 subvariant by half, CDC finds
See how to search.